Moreover, EA inhibited osteoclast differentiation in vitro through the TRAF6-dependent PI3K/Akt and NF-κB signalling pathways and decelerated osteoporosis progression in the OVX rat model. The gene discussed is AKT1; the disease is osteoporosis.